This group aims to identify novel pharmacological targets for treating acute cerebrovascular disease, which is the second largest cause of death in the western world. The group focuses on the very ...

If MR imaging is readily available and suspicion for acute CVA is high, then directly proceeding with MR is the sensible path. If MR imaging is not readily available and your suspicion is high for ...

Liraglutide, a GLP-1 significantly lowers the rate of recurrent stroke in patients with diabetes, with no apparent increase ...